So that patient might be a candidate." The trial included 410 patients, ages 18-85, who received a surgical bioprosthetic aortic or mitral valve or both. Extremely high bleeding risk patients were ...
But even accepting that, this was on the lower end of what is generally achieved.” For the study, Izumi and colleagues randomized 410 patients (mean age 73 years) who underwent mitral and/or aortic ...
The randomized, multi-center trial included approximately 400 adults in Japan who had bioprosthetic heart valve replacement surgery at the aortic and/or mitral position. Researchers randomized the ...
Our initial endocardiography examination showed severe mitral valve stenosis. All the cusps of the bioprosthesis appeared thickened, with marked subvalvular thrombosis. The patient was ...
P = 0.012), and combined aortic and mitral valve surgery (OR = 11.5, P = 0.027). Aortic valve types did not predict complete heart block (CHB) and PPM implantation. Of those patients who underwent ...